<DOC>
	<DOCNO>NCT02507492</DOCNO>
	<brief_summary>The purpose study evaluate effect daily subcutaneous ( SC ) injection RM-493 , subject POMC ( propiomelanocortin ) relate rare genetic mutation , body weight , metabolic function blood pressure . Patients respond initial 84 day treatment enter long-term ( 2-year ) extension . The study drug ( RM-493 ) administer unblinded fashion .</brief_summary>
	<brief_title>RM-493 Treatment Trial Proopiomelanocortin ( POMC ) Deficient Patients</brief_title>
	<detailed_description />
	<mesh_term>Adrenocorticotropic Hormone</mesh_term>
	<mesh_term>Melanocyte-Stimulating Hormones</mesh_term>
	<mesh_term>beta-Endorphin</mesh_term>
	<criteria>Written inform consent Homozygous compound heterozygous ( different gene mutation allele ) POMC , LEPR PCSK1 gene mutation Obesity ( BMI &gt; 30 kg/m2 ; + 2 BMI SDS ) No therapeutic option , might cure patient ( e.g . bariatric surgery ( see chapter 8 ) ) Negative Pregnancy test Highly effective contraception woman ( define pearl index &lt; 1 ) , necessary also partner test person ) No participation clinical trial accord AMG ( Arzneimittelgesetz ) ( 2 month ) time trial Normal minimally elevate blood pressure ( measure 24RR monitoring similar method ) accord guideline ESH ( European Society Hypertension ) Deutsche Hochdruckliga : systolic &gt; 159 mmHg/diastolic 99 mmHg sufficient kidney liver function ( Creatinine , ALT , AST ) normal value AlanineAminotransferase ( ALT ) ( female ) : &lt; 31 U/l normal value AlanineAminotransferase ( ALT ) ( male ) : &lt; 41 U/l normal value AspartateAminotransferase ( AST ) ( female &gt; 17 year ) : &lt; 35 U/l ; ( female &lt; 17 year ) : 16 46 U/l normal value AspartateAminotransferase ( AST ) ( male &gt; 17 year ) : &lt; 50 U/l ; ( male &lt; 17 year ) : 1646 U/l normal value bilirubin ( male female ) 1,2 mg/dl normal value Creatinine ( female &gt; 15 year ) : 0,510,95 mg/dl ) ; ( female &lt; 15 year ) : 0,460,77 mg/dl normal value Creatinine ( male &gt; 15 year ) : 0,67 1,17 mg/dl ) ; ( male &lt; 15 year ) : 0,460,77 mg/dl Pregnancy Breastfeeding All contraindication study medication ( include auxiliary substance ) Interactions study medication Participation patient clinical study within last 2 month Intolerance albumin Concomitant diseases , impair organ function , except know , concurrent GI disorder clinical finding expect PCSK1 LEPR gene disorder Renal insufficiency ( Creatinine &gt; 0,95 mg/dl ( female ) , &gt; 1,17 mg/dl ( male ) ) Impaired liver function ( Bilirubins &gt; 1.2 mg/dl ) Neurological / psychiatric disease HIV Infection Active Hepatitis B C Melanoma Melanoma occurrence family history Noncompliance Subjects legally detain official institution</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2016</verification_date>
	<keyword>POMC , LEPR , PCSK1</keyword>
</DOC>